VIRMA and prostate adenocarcinoma: VIRMA was more lowly expressed in uterine corpus endometrial carcinoma (UCEC), thyroid carcinoma (THCA), prostate adenocarcinoma (PRAD) and kidney renal papillary cell carcinoma (KIRP).